PD-L1-IN-4

Description

PD-L1-IN-4 Compound X18 is an orally active PD-L1 inhibitor that exhibits remarkable inhibitory activity against the PD-1/PD-L1 interaction IC50 = 1.3 nM and enhances PD-L1 inhibitory effect on T cells EC50 = 152.8 nM . PD-L1-IN-4 can be used for the research of cancer.